Ras pathway mutations were recurrent in pediatric B-ALL [24, 30, 31], and the vast majority of mutations occurred in KRAS, NRAS, FLT3 and NF1, revealing a central role of these genes in pediatric B-ALL. The gene discussed is NRAS; the disease is precursor B-cell acute lymphoblastic leukemia.